SAM
Simplify Asset Management Portfolio holdings
AUM
$1.65B
This Quarter Return
+6.01%
1 Year Return
+8.73%
3 Year Return
+37.73%
5 Year Return
–
10 Year Return
–
AUM
$552M
AUM Growth
+$552M
(-1.1%)
Cap. Flow
-$48.2M
Cap. Flow
% of AUM
-8.73%
Top 10 Holdings %
Top 10 Hldgs %
71.78%
Holding
134
New
21
Increased
40
Reduced
21
Closed
23
Top Buys
| 1 |
Plains All American Pipeline
PAA
|
$9.17M |
| 2 |
Simplify Aggregate Bond ETF
AGGH
|
$3.48M |
| 3 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
$3.15M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$2.64M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$2.57M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$41.7M |
| 2 |
IBDO
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
|
$20.2M |
| 3 |
IBDP
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
|
$19.7M |
| 4 |
Invesco QQQ Trust
QQQ
|
$8.84M |
| 5 |
Simplify Volatility Premium ETF
SVOL
|
$8.6M |
Sector Composition
| 1 | Healthcare | 17.63% |
| 2 | Energy | 4.47% |
| 3 | Technology | 0.54% |
| 4 | Industrials | 0.28% |
| 5 | Consumer Discretionary | 0.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Mirum Pharmaceuticals
MIRM
$3.75B
| $1.81M | 0.24% |
70,000
| – | – |
|
52
AbbVie
ABBV
$374B
| $1.73M | 0.23% |
12,814
+3,168
| +33% | +$427K |
|
53
Thermo Fisher Scientific
TMO
$183B
| $1.7M | 0.22% |
3,258
+1,531
| +89% | +$799K |
|
|
MRNS
54
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.63M | 0.21% |
150,000
| – | – |
|
55
JPMorgan Ultra-Short Income ETF
JPST
$33B
| $1.6M | 0.21% |
+31,942
| New | +$1.6M |
|
56
iShares Floating Rate Bond ETF
FLOT
$9.12B
| $1.6M | 0.21% |
31,437
+26,937
| +599% | +$1.37M |
|
57
Cooper Companies
COO
$13.3B
| $1.55M | 0.2% |
16,124
+3,960
| +33% | +$380K |
|
58
PureCycle Technologies
PCT
$2.39B
| $1.53M | 0.2% |
143,490
+73,798
| +106% | +$789K |
|
59
Becton Dickinson
BDX
$54.3B
| $1.52M | 0.2% |
5,760
-305
| -5% | -$80.5K |
|
60
Telesat
TSAT
$307M
| $1.51M | 0.2% |
+160,781
| New | +$1.51M |
|
61
Avidity Biosciences
RNA
$6.12B
| $1.39M | 0.18% |
125,000
| – | – |
|
62
Stryker
SYK
$149B
| $1.37M | 0.18% |
4,484
+2,462
| +122% | +$751K |
|
63
Stoke Therapeutics
STOK
$1.08B
| $1.31M | 0.17% |
122,796
| – | – |
|
64
Allogene Therapeutics
ALLO
$249M
| $1.22M | 0.16% |
245,000
| – | – |
|
65
argenx
ARGX
$44.2B
| $1.2M | 0.16% |
+3,073
| New | +$1.2M |
|
66
Penumbra
PEN
$10.5B
| $1.2M | 0.16% |
+3,479
| New | +$1.2M |
|
67
Kayne Anderson Energy Infrastructure Fund
KYN
$2.07B
| $1.2M | 0.16% |
147,033
-65,205
| -31% | -$531K |
|
68
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.7B
| $1.07M | 0.14% |
+14,216
| New | +$1.07M |
|
69
Schwab US TIPS ETF
SCHP
$13.9B
| $1.07M | 0.14% |
+40,654
| New | +$1.07M |
|
|
KDNY
70
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $961K | 0.13% |
25,000
| – | – |
|
71
iShares Core US Aggregate Bond ETF
AGG
$130B
| $944K | 0.12% |
9,635
+3,414
| +55% | +$334K |
|
72
Establishment Labs
ESTA
$1.11B
| $884K | 0.12% |
12,878
+3,190
| +33% | +$219K |
|
73
Tenet Healthcare
THC
$16.5B
| $864K | 0.11% |
10,617
+2,618
| +33% | +$213K |
|
74
Gilead Sciences
GILD
$140B
| $864K | 0.11% |
11,210
+2,772
| +33% | +$214K |
|
75
Biogen
BIIB
$20.8B
| $851K | 0.11% |
+2,989
| New | +$851K |
|